SLC16A11 rs33985460: What Your Genotype Means
The genetic variant rs33985460 is a missense alteration located within the SLC16A11 gene on chromosome 17. It forms part of an ancestral haplotype that modifies hepatic lipid handling and cellular transport, correlating with a moderately higher risk of developing type 2 diabetes. Because the variant's prevalence and impact vary dramatically according to genetic background, understanding its role provides insight into complex metabolic health rather than a definitive diagnosis.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| CC | Carries two copies of the ancestral major allele. This genotype is not associated with the Neanderthal-derived risk haplotype in SLC16A11 and reflects baseline, average population-level genetic risk for hepatic lipid changes and type 2 diabetes. | Favorable |
| CT | Carries one copy of the missense risk allele alongside one standard allele. This heterozygous state is statistically associated with a modest increase (approximately 20%) in relative risk for type 2 diabetes, primarily characterized in populations with Indigenous American or Latino ancestry. | Higher attention |
| TT | Carries two copies of the missense risk allele on the SLC16A11 haplotype. Homozygous individuals show the highest observed additive risk for altered hepatic lipid handling and elevated diabetes odds within studied populations, though lifestyle factors remain the primary determinants of actual disease onset. | Higher attention |
Genetic Architecture and the rs33985460 Variant
The single nucleotide polymorphism rs33985460 resides on chromosome 17 within the coding sequence of SLC16A11. This variant is a missense mutation that substitutes an amino acid in the encoded transmembrane transport protein. Rather than acting in complete isolation, rs33985460 is in high linkage disequilibrium with a distinct group of variants on a contiguous 73-kilobase genomic block. Evolutionary genetic analyses indicate that this specific haplotype entered the modern human gene pool via archaic introgression from Neanderthals. While carrying this allele alters protein structure, its metabolic consequences are best understood as part of this tightly co-inherited multi-variant haplotype. Because genomic architecture varies across global populations, the Presence of rs33985460 reflects ancestral lineage patterns that have shaped how modern human populations manage energy storage and nutrient transport.
Biological Function of SLC16A11
The SLC16A11 gene encodes a member of the solute carrier family 16, specifically functioning as a proton-coupled monocarboxylate transporter. In human physiology, this transporter is expressed predominantly in the liver and plays a central role in hepatic lipid and carbohydrate metabolism. Functional studies demonstrate that the risk-associated haplotype acts through two distinct molecular consequences: it downregulates the overall expression of SLC16A11 in liver tissue and impairs the transport protein's interaction with the chaperone protein basigin, preventing proper localization to the cell membrane. This functional deficiency disrupts intracellular fatty acid oxidation and shifts hepatic lipid storage toward triacylglycerols and diacylglycerols. Over time, the resulting cellular accumulation of lipid intermediates impairs normal hepatic insulin signaling, contributing to systemic insulin resistance and altered glucose homeostasis.
Evidence Strength and Type 2 Diabetes Association
Large-scale genome-wide association studies (GWAS), initiated by the SIGMA Type 2 Diabetes Consortium, identified this locus as a notable contributor to metabolic risk. Each copy of the risk haplotype carries an approximate 20% increased relative risk of developing type 2 diabetes in affected groups. While the biological disruption in hepatic lipids is documented in laboratory models, overall epidemiological evidence is considered limited and ancestry-specific. Studies evaluating diverse cohorts show that the association is robust in Mexican, Latin American, and certain Indigenous American groups, but fails to reach statistical significance in non-Mexican Hispanic cohorts or other global groups. Furthermore, having an odds ratio of roughly 1.20 demonstrates that rs33985460 exerts a modest effect size typical of polygenic traits, functioning as an incremental risk factor rather than a deterministic cause.
Population Distribution Across Ancestries
The distribution of rs33985460 exhibits extreme global divergence due to historic human demographic movements and archaic admixture. The risk variant is common across Hispanic and Latino populations, where allele frequencies regularly reach 20% to 30%, and exceeds 50% in individuals with high proportions of Native American ancestry. In sharp contrast, the variant is nearly absent in populations of European and African descent, typically registering frequencies well below 1%. Intermediate frequencies are sometimes observed in certain East Asian groups. This pronounced disparity explains why early European-centric GWAS missed the locus entirely, highlighting the necessity of diverse genomic cohorts. It also means that the clinical relevance of rs33985460 as a contributor to population-level type 2 diabetes burden is largely restricted to individuals of Latin American and Indigenous American heritage.
Navigating Your Genetic Results Responsibly
Discovering that you carry one or two copies of rs33985460 does not mean you are destined to develop type 2 diabetes. Complex cardiometabolic conditions arise from interactions between hundreds of polygenic markers, nutrition, physical activity, sleep quality, and environmental stressors. Genetic results cannot diagnose insulin resistance, prediabetes, or clinical diabetes, nor can they measure your current blood glucose handling. If you learn that your genotype falls into a higher-attention category, the most constructive approach is to discuss routine metabolic screening—such as fasting blood glucose or hemoglobin A1c—with a primary care clinician. Medication dosing, dietary shifts, or pharmacologic decisions should never be based solely on raw genetic data, but rather on verified clinical laboratory panels interpreted in partnership with a qualified healthcare professional.
How common is this variant?
The rs33985460 risk allele is common in Hispanic and Latino populations (~20-30%) and reaches up to 50% in individuals with high Native American ancestry, but is exceedingly rare (<1%) in populations of European and African descent.
Frequently asked questions
Does having the rs33985460 risk allele mean I will get diabetes?
No. The variant confers a modest increase in relative risk (around 20% per allele copy) rather than causing the condition directly. Type 2 diabetes is a multifactorial disease influenced by hundreds of genetic variants alongside modifiable factors like diet, exercise, and weight management.
Why is rs33985460 more common in people of Hispanic or Latino descent?
The variant lies on a haplotype introduced into human ancestors via archaic introgression from Neanderthals that became preserved at higher frequencies in early Native American populations. Because of this ancestral history, it remains prevalent in modern Mexican, Latino, and Indigenous American gene pools while remaining very rare in European and African populations.
Can I use my rs33985460 status to guide my diabetes medication?
No, current clinical guidelines do not adjust medications or dosages based on SLC16A11 genotypes. Any questions regarding glycemic control, pharmaceutical treatments, or lab interpretations should always be evaluated with your prescribing doctor or pharmacist.
What does SLC16A11 do in the human body?
SLC16A11 produces a monocarboxylate transporter protein situated in liver cell membranes that helps manage lipid and carbohydrate metabolism. When function is diminished by this haplotype, liver cells accumulate specific lipid intermediates that can impair cellular insulin signaling.
Sources & further reading
Educational information only, last refreshed 9/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs33985460?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29